SB-480848 in Major Adverse Cardiovascular Events - Integrated Summary of Efficacy and Safety From the STABILITY Trial (LPL100601) and the SOLID-TIMI-52 Trial (SB-480848/033)

CompletedOBSERVATIONAL

Enrollment

28,855

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions

Coronary Heart Disease

Interventions

DRUG

darapladib

darapladib enteric coated tablets 160 mg

DRUG

placebo